Clearstead Advisors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$143 Buy
+5
New +$109 ﹤0.01% 3281
2026
Q1
Sell
-6
Closed -$114 2349
2025
Q4
$114 Sell
6
-14
-70% -$235 ﹤0.01% 2500
2025
Q3
$291 Sell
20
-91
-82% -$1.3K ﹤0.01% 2809
2025
Q2
$2.17K Buy
+111
New +$1.97K ﹤0.01% 2306

Other funds holding CDNA

Clearstead Advisors's CDNA Position: Q2 2026 in Review

Clearstead Advisors opened a new position in CareDx (CDNA) in Q2 2026: 5 shares worth $143. The stake represents ﹤0.01% of the portfolio and ranks #3281 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in CDNA as recently as Q4 2025.

Clearstead Advisors first reported a position in CDNA in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.17K in Q2 2025. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Clearstead Advisors held 5 shares of CareDx worth $143 as of Q2 2026.
  • CareDx was a new Clearstead Advisors position in Q2 2026.
  • CareDx made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3281 holding.
  • Clearstead Advisors first reported a position in CareDx in Q2 2025 and has held it in 4 quarters since.
  • Clearstead Advisors's CareDx position peaked at $2.17K in Q2 2025.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.